Azamat A. Gusalov

Azamat A. Gusalov

Auto-generated profile, based on publicly available information

Azamat A. Gusalov

North Ossetian State Medical Academy

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2024 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
DFDzgoeva U. Fatima
Dzgoeva U. Fatima
OROleg Remizov
Oleg Remizov
ZIZarina R. Ikoeva
Zarina R. Ikoeva
ITIlona V. Tedeeva
Ilona V. Tedeeva
AGAzamat A. Gusalov
Azamat A. Gusalov
РРРусский Русский
Русский Русский
Aim. To clarify the role of advanced glycation end products (AGEs) and inflammation in the development of vascular calcification and cardiovascular complications at different stages of chronic kidney disease (CKD) G1–G5D. Materials and methods. We examined 105 patients aged 19 to 75 years with stage C1–C5D CKD, 77 (74%) of whom were patients with diabetic nephropathy. The concentration of AGEs, interleukin (IL)-1, IL-6 and tumor necrosis factor α (TNF-α), troponin I, parathyroid hormone was determined by enzyme-linked immunosorbent assay (ELISA) using kits from BluGene biotech (Shanghai, China), Cloud-Clone Corp. (USA), ELISA Kit (Biomedica, Austria). Results. A high content of AGEs, IL-1, IL-6, TNF-α was established, which directly correlated with the increase in renal failure and changes in the morpho-functional parameters of the left ventricle and aorta. Conclusion. An increase in serum concentrations of AGEs and inflammatory mediators, correlating with a decrease in renal function and changes in the morpho- functional parameters of the left ventricle and aorta, indicate their significant role in the processes of damage to the cardiovascular system in CKD.

25 September 2026 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
PDF file
FDF. U. Dzgoeva
F. U. Dzgoeva
ITI. V. Tedety
I. V. Tedety
OROleg Remizov
Oleg Remizov
AGA. A. Gusalov
A. A. Gusalov
ZIZ. R. Ikoeva
Z. R. Ikoeva
МТМ. М. Теблоев
М. М. Теблоев
BACKGROUND. Vascular and cardiac calcification is an important contributor to cardiovascular complications in patients with chronic kidney disease (CKD) and is associated with oxidative stress and persistent low-grade inflammation. However, the interactions between these processes and their contribution to cardiovascular remodeling across different stages of CKD remain incompletely understood. THE AIM: to investigate the role of oxidative stress and persistent low-grade inflammation, as well as their interaction, in vascular calcification and cardiovascular remodeling across different stages of CKD. PATIENTS AND METHODS. The study included 110 patients with CKD across different stages, aged 20–69 years; 51 (46.4 %) were male. Markers of oxidative stress, including superoxide dismutase (SOD), glutathione, and malondialdehyde (MDA), and inflammatory markers, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), were assessed. Parameters of mineral and bone metabolism, as well as structural and functional characteristics of the heart and aorta, were also evaluated. RESULTS. Significant alterations in markers of oxidative stress and inflammation were observed. These changes became more pronounced with advancing CKD and were associated with the degree of left ventricular and aortic remodeling. CONCLUSION. Increased oxidative stress and persistent low-grade inflammation, as well as their interaction, may contribute to cardiovascular remodeling and complications in patients with CKD.

12 September 2023 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
PDF file
FDF. U. Dzgoeva
F. U. Dzgoeva
OROleg Remizov
Oleg Remizov
ZIZ. R. Ikoeva
Z. R. Ikoeva
VGV. G. Goloeva
V. G. Goloeva
AGA. A. Gusalov
A. A. Gusalov
Background. Vascular calcification underlies cardiovascular complications, which remain the leading cause of high mortality in chronic kidney disease (CKD). Uremic toxins, including the advanced glycation end products, play a significant role in the formation of this process.The Aim of the study is to clarify the role of the advanced glycation end products (AGEs) and inflammationproducts in the processes of vascular calcification at different stages of CKD.Patients and Methods. 105 patients aged 18 to 66 years at different stages of CKD C1-C5D were examined, 75 of which were caused by diabetic nephropathy (DN), 30 by other nosological forms. Serum concentrations of AGEs, IL6, TNF-α, troponin I, parathyroid hormone (PTH) were determined by enzyme immunoassay (ELISA). To study the AGEs concentration, the serum was separated by centrifugation (in Eppendorf tubes). The samples were stored at – 70 °C. The left ventricular myocardial mass index (LVMI) was determined. Left ventricular hypertrophy (LVH) was diagnosed with LVH>115 g/m2 for men and >95 g/m2 for women. The peak systolic velocity of blood flow in the aortic arch (Vps) was studied by duplex scanning using the Doppler effect.Results. A significant increase in serum phosphorus concentration (p < 0.05) and PTH (p< 0.01) was revealed as the glomerular filtration rate decreased. An increase in the concentration of AGEs, IL6 and TNF-α was found at all stages of CKD, most pronounced at the later stages – C4-C5D ((p< 0.01, p< 0.05, p˂0.05, respectively). Pronounced changes in LVMI and Vps were associated with high levels of AGEs, IL6 and TNF-α.Conclusion. An increase in the level of glycation end products and inflammatory factors directly and reliably correlated with the severity of uremia and the severity of morphofunctional changes in the heart and aorta, which confirms their significant role in the development of cardiovascular complications in CKD.